Nature medicine publishes first study utilizing nanostring's geomx digital spatial profiler whole transcriptome atlas

Seattle--(business wire)--nanostring technologies, inc. (nasdaq:nstg), a leading provider of life science tools for discovery and translational research, today announced the publication of a study in the journal nature medicine that used nanostring's geomx® digital spatial profiler (dsp) and the new whole transcriptome atlas (wta) to profile sarcoma tissue. the research was led by a team from the broad institute in cambridge, massachusetts. the paper, entitled “opposing immune and genetic mecha
NSTG Ratings Summary
NSTG Quant Ranking